Latest News & Features
Big Pharma
Amgen subsidiary Immunex has asked the US Supreme Court not to review a Federal Circuit decision that found the company did not patent the same rheumatoid arthritis invention twice. 14 April 2021
Generics
Repurposing drugs has very clear benefits. It gives companies the opportunity to develop entirely new uses for existing drugs that they don’t have patent protection, and may allow innovator companies to protect a molecule or formulation even after initial patent protection has expired. 13 April 2021
Big Pharma
Edwards Lifesciences will be able to proceed with its claims of trademark infringement over an artificial heart valve against Meril Life Sciences, according to a US federal court. 13 April 2021
Big Pharma
UK company C4X Discovery has agreed an exclusive licensing deal with Sanofi worth a potential €414 million, which will see the French pharmaceutical company develop anti-inflammatory therapies. 13 April 2021
Americas
Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19. 8 April 2021
article
Without patent protection, efforts to commercialise a repurposed drug have little chance for a reasonable return and are unlikely to attract outside investment. Repurposing drugs can be extremely fruitful for companies as long as proper patent protection is in place. There are a few barriers to consider when trying to patent protect repurposed drugs. 8 April 2021
Big Pharma
The UK government’s £20 million fund aimed at growing life sciences manufacturing is now open for applications, it confirmed today, April 7. 8 April 2021
Medtech
Honeywell has been targeted in a recent complaint from competitor Moldex-Metric over a newly-launched “antimicrobial” earplug dispenser, which Moldex claims is falsely advertised. 6 April 2021
Americas
Pharmaceutical companies defending an antitrust lawsuit have fought back against attempts to get them to disclose confidential information garnered through discovery during the litigation to the US Federal Trade Commission. 6 April 2021
Americas
A recent University of Texas dispute perfectly illustrates the differing role sovereign immunity takes in proceedings at the Patent Trial and Appeal Board and district court, say Simon Roberts, Nitya Anand and Eric Wang of Hogan Lovells. 6 April 2021